News & Events
- February 9, 2015
-
February 6, 2015
European Medicines Agency Qualifies ‘Hollow Fiber System’ For Anti-Tuberculosis Drug Development
February 6, 2015 European Medicines Agency Qualifies ‘Hollow Fiber System’ For Anti-Tuberculosis Drug Development Provides major boost for improved development of TB treatment to meet major public health challenge TUCSON, Ariz., February 6, 2015 – The Critical Path Institute (C-Path), an independent, nonprofit organization working to accelerate the process of drug and medical product development, announced... -
February 5, 2015
The Choice of Outcome Parameters and Need for Distinct Assessment Tools with Regard to the Different Disease Stages in Alzheimer’s Disease (Video)
Presenter – Martha Brumfield, PhD, President and CEO, Critical Path Institute Conference – European Medicines Agency workshop on the clinical investigation of medicines for the treatment of Alzheimer’s disease; November 24-25, 2014; London, UK Video courtesy of the European Medicines Agency. - February 5, 2015
- February 3, 2015
